Safety Evaluation of Bacillus subtilis IDCC1101, Newly Isolated from Cheonggukjang, for Industrial Applications

• Published in: Microorganisms (Basel) 2022-12, Vol.10 (12), p.2494
• Main Authors: Kim, Su-Hyeon, Yehuala, Gashaw Assefa, Bang, Won Yeong, Yang, Jungwoo, Jung, Young Hoon, Park, Mi-Kyung
• Format: Article
• Language: English
• Subjects: Alkaline phosphatase; Amines; Antibiotic resistance; Antibiotics; Antiinfectives and antibacterials; Bacillus subtilis; Bacillus subtilis IDCC1101; Biogenic amines; Carbohydrates; Drug resistance; Enzymatic activity; Enzyme activity; Enzymes; Esterase; Evaluation; Fungicides; Galactosidase; Gene sequencing; Genes; Genomes; genomic analysis; Glucosidase; industrial application; Industrial applications; Laboratories; Lactic acid; Metabolites; Phosphohydrolase; Probiotics; Safety; safety evaluation; Secondary metabolites; Streptomycin; Taxonomy; Toxicity; Toxins; Virulence; α-Glucosidase; β-Galactosidase; β-Glucosidase
• ISSN: 2076-2607; 2076-2607
• DOI: 10.3390/microorganisms10122494

The present study aimed to evaluate the safety of (BS) IDCC1101, newly isolated from Cheonggukjang in Korea. Genome sequencing of BS IDCC1101 was performed to investigate the presence of secondary metabolites, virulence, antibiotic resistance, and mobile elements. Its phenotypic safety analyses included antibiotic susceptibility, enzyme activity, carbohydrate utilization, production of biogenic amines (BAs) and D-/L-lactate, hemolytic activity, and toxicities in HaCaT cells and rats. The genome of BS IDCC1101 consisted of 4,118,950 bp with 3077 functional genes. Among them, antimicrobial and antifungal secondary metabolites were found, such as fengycin, bacillibactin, and bacilysin. Antibiotic resistance and virulence genes did not exhibit transferability since they did not overlap with mobile elements in the genome. BS IDCC1101 was susceptible to almost all antibiotics suggested for assessment of BS's antibiotic susceptibility by EFSA guidelines, except for streptomycin. BS IDCC1101 showed the utilization of a wide range of 27 carbohydrates, as well as enzyme activities such as alkaline phosphatase, esterase, esterase lipase, naphthol-AS-BI-phosphohydrolase, α-galactosidase, β-galactosidase, α-glucosidase, and β-glucosidase activities. Additionally, BS IDCC1101 did not exhibit the production of D-/L-lactate and hemolytic activities. Its toxicity in HaCaT cells and rats was also not detected. Thus, these genotypic and phenotypic findings indicate that BS IDCC1101 can be safely used for industrial applications.